BioNTech Eyes Cancer Vaccines by 2030

The company behind one of the most successful COVID-19 vaccines wants to use their mRNA technology to take on cancer.

Bbc
BBC

BioNtech and Pfizer teamed up for one of the most successful vaccination campaigns in history. Now, according to a recent Interesting Engineering article, BioNTech says it has made breakthroughs that could lead to cancer vaccines in the near future. Professors Uğur Şahin and Özlem Türeci, the husband and wife team behind BioNTech, believe the mRNA technology used for their COVID-19 vaccine could be tweaked to make the immune system attack cancer cells rather than coronaviruses as soon as 2030.

Fresh from the show floor: pharma packaging innovations for 2026
Serialization mandates. Containment demands. Sterile barrier requirements. Our editors found the pharma packaging innovations addressing your biggest challenges at PACK EXPO Las Vegas. Get your free curated report now.
GET YOUR COPY
Fresh from the show floor: pharma packaging innovations for 2026